GLP1R and hydrops fetalis: Future studies should further investigate the mechanistic pathways of GLP-1 RAs, prescribing patterns in diverse populations, and evaluate their efficacy in patients with HF with preserved ejection fraction and lower BMI through randomized clinical trials.